Nasdaq
XLO
Xilio Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +1.8%
- 1 month
- −0.4%
- 1 year
- +0.3%
$9.27 · Mkt cap $61.0M
At the 6 Aug 2026 close
Nasdaq
Xilio Therapeutics, Inc.
$9.27 · Mkt cap $61.0M
At the 6 Aug 2026 close
Xilio Therapeutics, Inc. trades under the ticker XLO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2021. Its market capitalisation is $61.0M. The last closing price was $9.27, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +0.3%, and −0.4% over the past month. Returns are price returns and exclude dividends.
This page exists because XLO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.